ROHIT MEHRA
Pharmacy in Ann Arbor, MI
License number
Michigan 5315048445
Issued Date
Jan 19, 2011
Expiration Date
Jan 31, 2018
Category
Pharmacy
Type
CS - 3
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about ROHIT MEHRA at radaris.comName
Address
Phone
450 Yorkshire Blvd, Dearborn Heights, MI 48127
Professional information
See more information about ROHIT MEHRA at trustoria.com
Diagnosis And Treatment Of Breast Cancer
Diagnosis And Treatment Of Breast Cancer
US Patent:
2008020, Aug 28, 2008
Filed:
Nov 8, 2007
Appl. No.:
11/936871
Inventors:
Arul Chinnaiyan - Ann Arbor MI, US
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/41, G01N 33/68, A61P 35/00
US Classification:
514381, 436 64
Abstract:
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to AGTR1 and LBP markers for breast cancer.
Spink1 As A Prostate Cancer Marker And Uses Thereof
Spink1 As A Prostate Cancer Marker And Uses Thereof
US Patent:
2010012, May 27, 2010
Filed:
Nov 8, 2007
Appl. No.:
12/513637
Inventors:
Arul M. Chinnaiyan - Plymouth MI, US
Scott A. Tomlins - Ann Arbor MI, US
Daniel R. Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Scott A. Tomlins - Ann Arbor MI, US
Daniel R. Rhodes - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 435 71
Abstract:
Compositions and methods for cancer research, diagnosis, and treatment, including but not limited to, cancer markers are provided. In particular, SPINK1 and other markers for prostate cancer are provided.
Rohit Mehra, Ann Arbor MI
Rohit Mehra, Ann Arbor MI
Specialties:
Anatomic Pathology
Address:
1500 E Medical Center Dr SUITE 2ND, Ann Arbor 48109
(800) 862-7284 (Phone), (734) 615-2964 (Fax)
(800) 862-7284 (Phone), (734) 615-2964 (Fax)
Certifications:
Anatomic Pathology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 2ND, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Rohit Mehra, Ann Arbor MI
Rohit Mehra, Ann Arbor MI
Specialties:
Pathologist
Address:
3621 S State St, Ann Arbor, MI 48108
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Recurrent Gene Fusions In Prostate Cancer
Recurrent Gene Fusions In Prostate Cancer
US Patent:
2007021, Sep 13, 2007
Filed:
Sep 12, 2006
Appl. No.:
11/519397
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Plymouth MI, US
Rohit Mehra - Ann Arbor MI, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Belmont MA, US
Lee Charles - Marlborough MA, US
Mark Rubin - Cambridge MA, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Plymouth MI, US
Rohit Mehra - Ann Arbor MI, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Belmont MA, US
Lee Charles - Marlborough MA, US
Mark Rubin - Cambridge MA, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital, Inc. - Boston MA
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
Recurrent Gene Fusions In Prostate Cancer
US Patent:
2012029, Nov 22, 2012
Filed:
May 30, 2012
Appl. No.:
13/483142
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C07K 16/18
US Classification:
5303897
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
Recurrent Gene Fusions In Prostate Cancer
US Patent:
2013004, Feb 14, 2013
Filed:
May 30, 2012
Appl. No.:
13/483157
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C40B 40/06, C07H 21/04
US Classification:
506 16, 536 2431, 536 234
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Recurrent Gene Fusions In Prostate Cancer
Recurrent Gene Fusions In Prostate Cancer
US Patent:
8211645, Jul 3, 2012
Filed:
Dec 30, 2009
Appl. No.:
12/650164
Inventors:
Scott Tomlins - Ann Arbor MI, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Daniel Rhodes - Ann Arbor MI, US
Arul Chinnaiyan - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Mark A. Rubin - New York NY, US
Xiao-Wei Sun - New York NY, US
Sven Perner - Ellwaugen, DE
Charles Lee - Marlborough MA, US
Francesca Demichelis - New York NY, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
The Brigham and Women's Hospital - Boston MA
The Brigham and Women's Hospital - Boston MA
International Classification:
C12Q 1/68, C12P 19/34, C07H 21/04
US Classification:
435 612, 435 912, 435810, 536 221, 536 243
Abstract:
Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
Adrb2 Cancer Markers
Adrb2 Cancer Markers
US Patent:
2012004, Feb 23, 2012
Filed:
Nov 1, 2011
Appl. No.:
13/286820
Inventors:
Arul M. Chinnaiyan - Plymouth MI, US
Jindan Yu - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Jindan Yu - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C40B 30/04, G01N 21/64, G01N 33/53, C12Q 1/68, C40B 30/00
US Classification:
506 9, 435 612, 506 7, 436501, 435 71
Abstract:
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ADRB2 markers for cancer.
Adrb2 Cancer Markers
Adrb2 Cancer Markers
US Patent:
8058003, Nov 15, 2011
Filed:
Jan 18, 2008
Appl. No.:
12/016498
Inventors:
Arul M. Chinnaiyan - Plymouth MI, US
Jindan Yu - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Jindan Yu - Ann Arbor MI, US
Rohit Mehra - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12Q 1/68, C12P 19/34, G01N 33/53, C07H 21/02, C07H 21/04
US Classification:
435 61, 435 71, 435 912, 536 231
Abstract:
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ADRB2 markers for cancer.